Hi there, 
 

Have a 5+ person startup and want 2022 to be your worst year ever?

Here are 18 things you should do to guarantee your startup leaves 2022 weaker than when you started.

1) Keep the high-performing a**hole on your team.

You've got a small team and 1 of them is an epic jerk. But he's really good at his job.

Don't worry.

He'll get better. And he's just that important. 

Keep him.

Plus, your other teammates don't have other options in this job market.

2) It's all about product-led growth so ensure you have that.

It used to be about gamification, freemium, or whatever.

But if you don't have PLG, are you even doing a startup?

See what folks are saying is the way to grow a startup.

And do it ASAP!

Outsource your thinking to others.

3) Don't talk to customers or users.

You have a vision. 

Stick to it.

Read the other 15 tips here (and be sure to blindly follow this advice).

A whole lotta change

The pandemic forced companies in industries as wide ranging as healthcare, education, and finance to use technology to reimagine nearly every facet of their operations.

Now almost 2 years into the pandemic, we explore 25 industries & tech shaping the post-Covid world — and which ones are posed to thrive — in this report.

Big pharma v.2

Big tech is making moves in the pharma industry. 

Amid an explosion in healthcare data and use cases for AI, giants like Amazon, Microsoft, Google, and Apple are building tech to streamline everything from drug discovery to remote patient monitoring. 

We analyze which pieces of the pharma value chain big tech is attacking, their strategies, and more in this report.

Just in time

We've extended the deadline to apply for the upcoming Retail Tech 100 awards to December 21. Make sure to fill out the initial application before then. 

So many logos

The unicorn market map is back, now with 936 companies worth a collective $3T+. 

Seventy-five percent of them have joined the club since 2019. 

See which categories are best represented and the companies that top the list here. 

Digital medicine

Diabetes is a leading driver of medical costs globally. In the US, over 10% of the population lives with the chronic condition. 

Digital therapeutics (DTx) for diabetes are helping drive down medical costs for payers and improve the success of diabetes prevention for members.

If you are looking to understand the DTx for diabetes landscape or initiate a vendor selection process, download our 53-page ESP Vendor Assessment report here.

The Economist. The Economist discusses the mental health app boom and references CB Insights data.

Inc. Melissa Angell (@melissajourno) cites Microsoft’s CMO and VP of Healthcare David Rhew’s (@drhew) comments on healthcare AI at the CBI Future of Health conference.

WIRED. Uche Adegbite (@enuhau) writes about global innovation and mentions CB Insights research. 

P.S. We’re looking for a business development manager. Apply here.